News

Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing
Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...
Kenvue: New CEO, Watch The Dividend (Rating Downgrade)
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
Kenvue ties up with API to launch ‘Cough Clinics’ to train Drs
With the duration and frequency of cough episodes increasing among Indians since the onset of COVID-19, Kenvue, the world’s ...
Business Wire3d
Kenvue Announces CEO Transition and Actions to Unlock Shareholder Value
Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company ...
Stock Movers: Coinbase, Kenvue, Synopsis
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Kenvue Inc. stock rises Wednesday, outperforms market
Kenvue Inc. closed 13.19% below its 52-week high of $25.17, which the company achieved on May 8th.
Explore more
Barchart on MSN1d
Kenvue's Q2 2025 Earnings: What to Expect
Kenvue is expected to release its second-quarter earnings next month, and analysts anticipate a double-digit profit dip.
6KVUE : Assessing Kenvue: Insights From 6 Financial Analysts
The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...